Lrig1 antibody (AA 35-220)
-
- Target See all Lrig1 Antibodies
- Lrig1 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))
-
Binding Specificity
- AA 35-220
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This Lrig1 antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Sequence
- AGPRAPCAAA CTCAGDSLDC GGRGLAALPG DLPSWTRSLN LSYNKLSEID PAGFEDLPNL QEVYLNNNEL TAVPSLGAAS SHVVSLFLQH NKIRSVEGSQ LKAYLSLEVL DLSLNNITEV RNTCFPHGPP IKELNLAGNR IGTLELGAFD GLSRSLLTLR LSKNRITQLP VRAFKLPRLT QLDLNR
- Cross-Reactivity
- Human, Mouse
- Characteristics
- Polyclonal Antibodies
- Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 35-220 of human LRIG1 (NP_056356.2).
- Isotype
- IgG
- Top Product
- Discover our top product Lrig1 Primary Antibody
-
-
- Application Notes
- WB,1:1000 - 1:2000
- Comment
-
HIGH QUALITY
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- Lrig1 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))
- Alternative Name
- LRIG1 (Lrig1 Products)
- Synonyms
- LIG-1 antibody, LIG1 antibody, D6Bwg0781e antibody, Img antibody, leucine rich repeats and immunoglobulin like domains 1 antibody, leucine-rich repeats and immunoglobulin-like domains 1 antibody, LRIG1 antibody, Lrig1 antibody
- Background
- Acts as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.,LRIG1,LIG-1,LIG1,Cancer,Tumor suppressors,LRIG1
- Molecular Weight
- 116 kDa/119 kDa
- Gene ID
- 26018
- UniProt
- Q96JA1
-